Mapping adverse events and monitoring priorities for trastuzumab deruxtecan use in metastatic breast cancer

Published: 21 July 2025| Version 1 | DOI: 10.17632/2xtgy2kr5v.1
Contributor:
qingmo yang

Description

This dataset contains supplementary materials for the manuscript entitled "Mapping adverse events and monitoring priorities for trastuzumab deruxtecan use in metastatic breast cancer."

Files

Institutions

  • Xiamen University

Categories

Clinical Pharmacology, Drug Adverse Reactions, Breast Cancer, Drug Safety

Licence